|
XOMA Corp.
Ticker Symbol: XOMA CUSIP: 98419J206 Previous CUSIP: G9825R206 Exchange: NGM
Company's Online Profile
BUSINESS: XOMA Corp. is a biotechnology company with a diverse portfolio of innovative therapeutic antibodies. The Company’s innovative product candidates are the result of its expertise in developing ground-breaking monoclonal antibodies, which have created new opportunities to potentially treat a wide range of endocrine diseases.
|
Find All Related Securities for XOMA
Notes: October 18, 2016 -- XOMA Corp. (XOMA) will effect a one-for-twenty (1-20) reverse split of its common stock. The CUSIP number will change to 98419J206.
|
Previous Name: XOMA Ltd.
Mid Cap Stock -
Market Value $ Million
Click for current XOMA price quote from the NASDAQ
|
Company's Online Information Links
|
| Company's Online SEC EDGAR Filings |
| Company's Email Address Links |
| Address and Phone Numbers |
| Address: 2200 Powell Street, Suite 310, Emeryville, CA 94608 |
| Main Phone Number |
510-204-7200 |
| Fax Number |
Not Available |
| Investor Relations
Juliane Snowden, Oratorium Group, LLC.
|
646-438-9754
|
| CEO - James R. Neal |
CFO - Thomas M. Burns |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
